Product image of Iopamiro (Iopamidol) supplied by GNH India

Iopamiro

Active Ingredient:
Iopamidol
Origin:
EU

Iopamiro (Iopamidol)

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intra‑arterial and intravenous use. It provides radiographic contrast enhancement for angiography and computed tomography (CT) scans in patients undergoing diagnostic imaging procedures.

GNH India supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet clinical demand. Products are manufactured under EU regulations and are available in multiple vial sizes to suit various imaging protocols.

Manufacturer / TM Owner

Bracco Imaging S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iopamiro is an iodinated contrast agent used in radiographic imaging to improve visualization of vascular and tissue structures.

  • Angiography: Provides enhanced visualization of blood vessels during intra‑arterial imaging procedures.
  • Computed Tomography (CT) scans: Improves contrast of anatomical structures, aiding diagnosis in CT imaging.

How It Works

  • Iopamidol works by delivering a high concentration of iodine atoms within the bloodstream. Iodine has a high atomic number, which strongly attenuates X‑ray photons. When administered intravenously or intra‑arterially, the iodine‑rich solution circulates through vessels and tissues, increasing radiodensity and creating a clear contrast between structures on X‑ray‑based imaging modalities such as angiography and CT. The resulting difference in attenuation allows clinicians to delineate anatomical details that would otherwise be indistinguishable.

Side Effects

Iopamiro may be associated with a range of adverse reactions, ranging from mild and transient to potentially serious.

Common Side Effects

  • Warmth or flushing sensation at the injection site.
  • Metallic or bitter taste in the mouth.
  • Mild nausea or vomiting.
  • Headache or mild dizziness.
  • Transient itching or urticaria.
  • Injection site pain or discomfort.

Serious or Rare Side Effects

  • Severe allergic reactions, including anaphylaxis.
  • Acute hypotension or cardiovascular collapse.
  • Contrast‑induced nephropathy leading to renal impairment.
  • Seizures or neurologic disturbances.
  • Cardiac arrhythmias.
  • Pulmonary edema or respiratory distress.

Precautions & Warnings

Prior to administration, clinicians should evaluate patient-specific risk factors and monitor for adverse events.

  • Assess renal function: check serum creatinine and eGFR before use.
  • Review allergy history: avoid in patients with known iodine or contrast media hypersensitivity.
  • Use the lowest effective dose to achieve diagnostic quality.
  • Monitor vital signs during and after injection, especially in high‑risk patients.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Iopamiro can interact with certain medications, necessitating careful management to reduce risk.

Major Interactions (Avoid)

  • Metformin: discontinue before and after contrast exposure to prevent lactic acidosis.
  • NSAIDs: avoid concurrent use due to increased risk of renal toxicity.
  • Aminoglycoside antibiotics: avoid as they may potentiate nephrotoxic effects.
  • Diuretics: use with caution; may exacerbate renal impairment.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor renal function and consider temporary suspension.
  • Beta‑blockers: may mask hypotensive responses.
  • Thyroid hormone preparations: monitor thyroid function as iodine load can affect hormone levels.

Frequently Asked Questions

Iopamiro is used as an iodinated contrast agent to enhance the visibility of blood vessels and internal organs during angiographic procedures and computed tomography (CT) scans. It helps radiologists obtain clearer images for accurate diagnosis.

Iopamidol contains a high concentration of iodine atoms, which absorb X‑ray photons more effectively than surrounding tissues. When injected, it circulates through the bloodstream, increasing radiodensity and creating a contrast difference that highlights vascular and tissue structures on imaging studies.

The dose of Iopamiro is determined by the prescribing physician based on the specific imaging procedure, patient weight, and clinical considerations. Dosage recommendations are provided in the product labeling and should be individualized for each patient.

The safety of Iopamiro in pregnancy and lactation has not been fully established. It should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order Iopamiro, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Iopamiro (iopamidol) is a low‑osmolality, non‑ionic iodinated contrast medium offering high image quality with a lower incidence of adverse reactions compared with older high‑osmolality agents. Its safety profile and efficacy make it a preferred choice for many angiographic and CT applications.

Iopamiro should be stored at 2‑8 °C in a refrigerator. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution to maintain stability and potency.

Iopamiro is administered as a sterile solution for injection, delivered intravenously or intra‑arterially by a qualified healthcare professional. The injection rate and volume are adjusted according to the imaging protocol and patient characteristics.

Serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and cardiovascular events like hypotension or arrhythmias. Prompt monitoring and appropriate emergency measures are essential during and after administration.

Iopamiro should be avoided in patients with a known hypersensitivity to iodinated contrast media, severe renal impairment, uncontrolled hyperthyroidism, or those who have experienced prior severe reactions to similar agents. Clinical judgment is required to assess suitability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.